Related Experiment Video
Updated: Apr 16, 2026

Combining Reflectance Confocal Microscopy with Optical Coherence Tomography for Noninvasive Diagnosis of Skin Cancers via Image Acquisition
Published on: August 18, 2022
[Basal cell carcinoma with matrical differentiation]
Gabrielle Goldman-Lévy1, Eric Frouin1, Isabelle Soubeyran2
1Laboratoire d'anatomie et cytologie pathologiques, hôpital Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier cedex, France.
Basal cell carcinoma with matrical differentiation is a rare tumor. This study investigates the role of beta-catenin in its development, offering insights into its histogenesis.
Area of Science:
- Dermatopathology
- Oncology
- Molecular Biology
Background:
- Basal cell carcinoma (BCC) is the most common human cancer.
- Basal cell carcinoma with matrical differentiation (BCC-MD) is an exceptionally rare variant.
- The physiopathogenesis of BCC-MD is not fully understood.
Observation:
- This study presents a novel case of BCC-MD.
- Immunohistochemical and molecular analyses of beta-catenin were performed.
- The tumor exhibited basaloid lobules differentiating towards pilar matrix cells.
Findings:
- Beta-catenin is implicated in the physiopathogenesis of matrical tumors.
- This analysis provides further evidence for beta-catenin's role in BCC-MD.
- The study aims to elucidate the histogenesis of this rare BCC variant.
Implications:
- Understanding beta-catenin's role may lead to targeted therapies for BCC-MD.
- This research contributes to the knowledge of rare skin cancer variants.
- Further investigation into beta-catenin signaling pathways is warranted.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cellular Differentiation
A zygote is a...
Basal Lamina are the Specialized Form of ECM
Proteins...
Multipotency and Niche of Bulge Stem Cell
Renewal of Skin Epidermal Stem Cells
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

